Contents of this document
- Launch of the ColorEdge CG3200X color-management OLED monitor
- Strengthen competitiveness in the Creative Work market by introducing new OLED monitor products from the second half of the fiscal year
- First selection for the FTSE JPX Blossom Japan Index
- B&P sales¥71.9 100 millionYear on year against the same period last year116.6%
- Healthcare revenue¥171.5 100 millionYear on year against the same period last year106.3%
- Creative Work sales¥21.5 100 millionYear on year against the same period last year88.6%
- V&S sales¥75.7 100 millionYear on year against the same period last year140.8%
- Amusement sales¥37.6 100 millionYear on year against the same period last year91.3%
- Sales in China113.2% YoY
- North America Sales121.3% YoY
- Europe Sales106.0% YoY
- Sales in Japan112.7% YoY
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥406.9 100 million (YoY +7.5%) |
| Operating profit | ¥18.1 100 million (YoY +175.1%) |
| Ordinary income | ¥24.51 100 million (YoY +64.3%) |
| Net income | ¥49.38 100 million (YoY +430.7%) |
| Gross Profit Margin | 34.3% |
| Operating profit margin | 4.5% |
| Selling, general and administrative expenses | ¥121.2 100 million |
| Results for the three months of the current quarter | For 26Q2, three-month standalone trends are shown for sales by market, sales by region and SG&A expenses. Three-month standalone figures in the consolidated income statement: Not disclosed |
| Full-year earnings forecast | Net Sales ¥85,000 million / Gross profit ¥27,700 million / Selling, general and administrative expenses ¥24,400 million / Operating profit ¥3,300 million / Ordinary income ¥4,600 million / Profit attributable to owners of the parent ¥6,500 million |
| Self-assessment against the plan | Current performance is progressing smoothly, ahead of plan |
| Segment results | B&P Net Sales ¥71.9 100 million / yoy_pct ¥16.6 100 million / Healthcare Net Sales ¥171.5 100 million / yoy_pct ¥6.3 100 million / Creative Work Net Sales ¥21.5 100 million / yoy_pct ¥-11.4 100 million / V&S Net Sales ¥75.7 100 million / yoy_pct ¥40.8 100 million / Amusement Net Sales ¥37.6 100 million / yoy_pct ¥-8.7 100 million / Other Net Sales ¥28.5 100 million / yoy_pct ¥-22.2 100 million / Segment profit Not disclosed |
| Breakdown of Factors Affecting the Change | Net Sales B&P +¥1,022 million / Healthcare +¥1,020 million / Creative Work -¥277 million / V&S +¥2,195 million / Amusement -¥359 million / Other -¥778 million / Operating profit Foreign Exchange Effects +¥329 million / Impact of higher revenue +¥218 million / Gross Margin Impact +¥528 million / Reduction in Selling, General and Administrative Expenses +¥81 million |
| Key KPIs | Indicator name B&P sales / Value ¥71.9 100 million / Year on year against the same period last year 116.6%, Indicator name Healthcare revenue / Value ¥171.5 100 million / Year on year against the same period last year 106.3%, Indicator name Creative Work sales / Value ¥21.5 100 million / Year on year against the same period last year 88.6%, Indicator name V&S sales / Value ¥75.7 100 million / Year on year against the same period last year 140.8%, Indicator name Amusement sales / Value ¥37.6 100 million / Year on year against the same period last year 91.3%, Indicator name Sales in China / Value 113.2% YoY, Indicator name North America Sales / Value 121.3% YoY, Indicator name Europe Sales / Value 106.0% YoY, Indicator name Sales in Japan / Value 112.7% YoY |
| Assumptions Underlying the Business Outlook | USD Annual Average Exchange Rate ¥160.00 / EUR Annual Average Exchange Rate ¥175.00 / Operating Profit FX Sensitivity A ¥1 depreciation against the US dollar: -¥80 million; a ¥1 depreciation against the euro: +¥100 million |
| Medium-term management plan targets | Ninth Medium-Term Management Plan Over the three years from the fiscal year ending March 2027 through the fiscal year ending March 2029, evolve into an imaging solutions company and reform the earnings structure / Annual Dividend Plans to maintain the ¥115 dividend / Total payout ratio target 70%+ of consolidated net income |
| Financial targets | ROA of 2.3% and ROE of 5.6% are stated. Target values: Not disclosed |
| Annual Dividend | Annual Dividend ¥115 /share / Interim Dividend ¥57.5 per share / Year-end dividend ¥57.5 per share |
| Payout ratio | Payout ratio 65.1% / Total payout ratio target 70%+ of consolidated net income |
| Acquisition of treasury shares | Acquisition amount ¥170 100 million (planned) / Period Not disclosed |
| Capital expenditures | ¥7.9 100 million |
| New initiatives | Launch of the ColorEdge CG3200X color-management OLED monitor, Strengthen competitiveness in the Creative Work market by introducing new OLED monitor products from the second half of the fiscal year, First selection for the FTSE JPX Blossom Japan Index |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Increased sales to the V&S market, higher domestic and overseas sales of B&P products, solid sales for air traffic control and defense applications, and the weaker yen against the euro contributed to higher revenue and profit. On the profit side, the gross profit margin rose due to increased sales of high-value-added products, while reductions in fixed costs from restructuring and streamlining the organizational structure in Europe and the absence of the one-time costs for the new technology building recorded in the same period of the previous year pushed up operating profit. Net income included a gain of ¥4.46 billion on the sale of investment securities.